Im Folgenden finden Sie ausgewählte Literaturangaben zum Thema Weihrauch. Weitere Literaturangaben bzw. Studien finden Sie auf der unabhängigen Informationsplattform

Gerne können Sie uns auch kontaktieren:

Literatur zum Thema Weihrauch – eine Auswahl

Weihrauch Literatur zum Thema Analytik

  1. Paul, M. Efficient preparation of incensole and incensole acetate, and quantification of these bioactive diterpenes in Boswellia papyrifera by a RP-DAD-HPLC method. Nat. Prod. Commun. 2012 Mar; 7 (3):283-8
  2. Paul, M. A thin-layer chromatography method for the identification of three different olibanum resins (Boswellia serrata, Boswellia papyrifera and Boswellia carterii, respectively, Boswellia sacra). Phytochem. Anal. 2012 Mar-Apr; 23 (2): 184-9

Weihrauch Literatur zum Thema Entzündung

  1. Henkel, A. Boswellic acids from frankincense inibit lipopolysaccharide functionality through direct molecular interference. Biochem. Pharmacol. 2012 Jan; 83 (1): 115-21
  2. Siemoneit, U. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. British Journal of Pharmacology 2011 Jan; 162(1); 147-162
  3. Tausch, L. Identification of human Cathepsin G as a functional target of boswellic acids from anti-inflammatory remedy frankincense. J. Immunol. 2009 Sep. 1; 183 (5): 3433-42
  4. Siemoneit, U. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance. Eur. J. Pharmacol. 2009 Mar 15; 606 (1-3): 246-54
  5. Siemoneit, U. Identification and functional analysis of Cyclooxygenase-1 as a molecular target of boswellic acids. Biochem. Pharmacol. 2008 Jan 15; 75 (2): 503-13
  6. Chrubasik, JE. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res. 2007 Jul; 21 (7):675-83.
  7. Chrubasik, JE. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res. 2007 Jul; 21 (7):675-83.
  8. Mee, JB. The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol. 2007 Jul; 171 (1):32-42.
  9. Yoo, H. Insulin-like growth factor-II regulates the 12-lipoxygenase gene expression and promotes cell proliferation in human keratinocytes via the extracellular regulatory kinase and phosphatidylinositol 3-kinase pathways. Int J Biochem Cell Biol. 2007; 39 (6):1248-59.
  10. Ammon, HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006 Oct; 72(12):1100-16.
  11. Banno, N. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol. 2006 Sep 19; 107 (2):249-53.
  12. Anthoni, C. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006 Jun; 290 (6):G1131-7.
  13. Poeckel, D. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase, Mol Pharmacol. 2006, 70, 1071-1078
  14. Poeckel, D. Boswellic acids: biological actions and molecular targets (Invited Review). Current Med Chem. 2006, 28, 3359-3369
  15. Takada, Y. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006 Mar 1;176(5):3127-40
  16. Poeckel, D. Induction of central signaling pathways and select functional effects in human platelets by ß-boswellic acid. Br. J. Pharmacol. 2005, 146, 514-524.
  17. Chevrier, MR. Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol. 2005 May; 12 (5):575-80.
  18. Reichling, J. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweiz Arch Tierheilkd. 2004 Feb; 146 (2):71-9.
  19. Altmann, A. Coupling of boswellic acid-induced Ca2+-mobilization and MAPK activation to lipid metabolism and peroxide formation in human leukocytes. Br J Pharmacol. 2004, 141, 223-232
  20. Kimmatkar, N. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial. Phytomedicine. 2003 Jan; 10 (1):3-7.
  21. Altmann, A. Boswellic acids activate p42MAPK and p38 MAPK and stimulate the mobilisation of calcium. Biochem Biophys Res Commun. 2002, 190, 185-190.
  22. Ammon, H. P. [Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases]. Wien Med Wochenschr. 2002; 152 (15-16):373-8.
  23. Huang, MT. Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid. Biofactors. 2000; 13 (1-4):225-30.
  24. Gupta, I. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998 Nov 17;3(11):511-4
  25. Sander, O. [Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study]. Z Rheumatol. 1998 Feb; 57 (1):11-6.
  26. Duwiejua, M. Anti-inflammatory activity of resins from some species of the plant family Burseraceae. Planta Med. 1993 Feb; 59 (1):12-6.
  27. Singh, GB. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions. 1986 Jun; 18 (3-4):407-12.

Übersichtspublikationen zu Weihrauch

  1. Abdel-Tawab, M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin. Pharmacokinet. 2011 Jun; 50 (6): 349-69